pembrolizumab
merck
['pembro', 'head and neck']
patients with locally advanced head and neck squamous cell carcinoma did not show statistically significant improvement in event-free survival with pembrolizumab plus chemoradiation vs chemoradiation alone. #hancsm #esmo2022 | 
Oncology news and insights from leading researchers and cancer centers.